Defective Anks1a disrupts the export of receptor tyrosine kinases from the endoplasmic reticulum

Soochul Park1

  • 1Department of Biological Science, Sookmyung Women's University, Seoul 04310, Korea.

BMB Reports
|November 3, 2016
PubMed

Insights

Ankyrin repeat and sterile alpha motif containing 1A (Anks1a) protein facilitates ErbB2 packaging into vesicles, reducing breast tumor growth. Anks1a is crucial for ErbB2-driven tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • EphA2 receptor tyrosine kinase amplifies ErbB2 signaling in tumorigenesis.
  • The role of Anks1a, an EphA2-interacting protein, in EphA2-mediated tumorigenesis is not fully understood.

Purpose of the Study:

  • To elucidate the precise function of Anks1a in the context of EphA2 and ErbB2 signaling in breast cancer.
  • To investigate the molecular mechanisms by which Anks1a influences ErbB2 trafficking and tumorigenesis.

Main Methods:

  • Phosphorylation-dependent Anks1a localization to the endoplasmic reticulum (ER).
  • Co-immunoprecipitation assays to determine binding interactions between Anks1a, EphA2, and Sec23.
  • Anks1a and EphA2 knockout mouse models to assess tumorigenesis.
  • Anks1a knockdown in primary mammary tumor cells overexpressing ErbB2.

Main Results:

  • Anks1a binds EphA2 via its Ankyrin repeats and Sec23 via its PTB domain.
  • Anks1a facilitates the selective packaging of EphA2 into COPII vesicles for transport.
  • Anks1a knockout mice exhibit reduced ErbB2-induced breast tumorigenesis, mirroring EphA2 knockout phenotypes.
  • Anks1a knockdown prevents ErbB2 cell surface localization and reduces ErbB2-driven mammary tumor growth.

Conclusions:

  • Anks1a plays a critical role in the molecular pathogenesis of breast tumors by mediating ErbB2 trafficking.
  • Anks1a's interaction with EphA2 is essential for stabilizing ErbB2 and facilitating its loading into COPII carriers.
  • Anks1a represents a potential therapeutic target for ErbB2-driven cancers and possibly other diseases.

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.1K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.7K
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
4.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K